Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients
Open Access
- 1 July 1991
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 64 (1) , 154-158
- https://doi.org/10.1038/bjc.1991.260
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patientsCancer, 1989
- Carcinoembryonic Antigen and Breast Carcinoma Antigen (CA 15.3) in Preoperative Staging and Postoperative Monitoring of Patients with Carcinoma of the BreastThe International Journal of Biological Markers, 1988
- Ca 15.3 as a Tumour Marker in Breast CancerThe International Journal of Biological Markers, 1987
- Serum Ca 15.3 Levels in Patients with Non-Tumoral Diseases, and Establishment of a Threshold for Tumoral Activity. Results in 1219 PatientsThe International Journal of Biological Markers, 1986
- Circulating Ca 15.3 Levels in Breast Cancer. Our Present ExperienceThe International Journal of Biological Markers, 1986
- Tumor Markers for Breast CarcinomaClinics In Laboratory Medicine, 1982
- Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft modelBritish Journal of Cancer, 1982
- RECOVERY OF IMMUNOLOGICALLY REACTIVE ANTIBODIES AND ANTIGENS FROM BREAST-CANCER IMMUNE-COMPLEXES BY PREPARATIVE ISOELECTRIC-FOCUSING1981
- Adjuvant endocrine therapy of primary operable breast cancer. Report on the Copenhagen breast cancer trials.1980
- Serum antibody in patients with mammary diseaseCancer, 1974